Stillbirth in week 19 of pregnancy followed by maternal death as a consequence of refused chemotherapy for non-hodgkin's lymphoma - Significance of adjuvant chemotherapy in women of reproductive age

Onkologie

Volumn 33, Issue 12, 2010, Pages 692-694

  Hauenstein, Evelyn ^a,b   Seidl, Stefan ^a   Schneider, Karl T M ^a   Fischer, Thorsten ^a,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Klinikum Starnberg   (Germany)

^c Krankenhaus Landshut Achdorf   (Germany)

Author keywords

Cancer in pregnancy; Chemotherapy in pregnancy; Fertility preservation; Gastric non Hodgkin's lymphoma; Premature ovarian failure

Indexed keywords

ANTINEOPLASTIC AGENT; ANTITHROMBIN III; CYCLOPHOSPHAMIDE; DOXORUBICIN; FIBRINOGEN; FRESH FROZEN PLASMA; PREDNISONE; THROMBOCYTE CONCENTRATE; VINCRISTINE;

ADNEXA DISEASE; ADULT; ARTICLE; AUTOPSY; BIOMETRY; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CASE REPORT; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; ENTEROCOCCUS FAECIUM; FEMALE; FETUS ECHOGRAPHY; GASTRECTOMY; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; HYDRAMNIOS; INDUCED ABORTION; INTERNATIONAL NORMALIZED RATIO; ITALY; KLEBSIELLA PNEUMONIAE; LAPAROTOMY; MATERNAL MORTALITY; NONHODGKIN LYMPHOMA; PARTIAL THROMBOPLASTIN TIME; PERIPHERAL T CELL LYMPHOMA; PERITONITIS; PREGNANCY DISORDER; RECTUM TEMPERATURE; SEPSIS; STILLBIRTH; STOMACH BIOPSY; STOMACH LYMPHOMA; STOMACH PERFORATION; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TREATMENT REFUSAL;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FATAL OUTCOME; FEMALE; GASTRECTOMY; HUMANS; INFERTILITY, FEMALE; LYMPHOMA, T-CELL, PERIPHERAL; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDNISONE; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY TRIMESTER, SECOND; PYLORIC ANTRUM; RUPTURE, SPONTANEOUS; SHOCK, SEPTIC; STILLBIRTH; STOMACH NEOPLASMS; STOMACH RUPTURE; TREATMENT REFUSAL; VINCRISTINE;

EID: 78649956537     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322213     Document Type: Article

References (18)

1. Hölscher G, Schmidt S, Dreyling M: Epidemiologie maligner Lymphome. Manual Maligne Lymphome des Tumorzentrum Münchens. München, Zuckschwerdt, 2008, pp 1-14.
2. Jemal A, Tiwari RC, Murray T, Ghaffor A, Samuels A, Ward E: Cancer statistics 2004. CA Cancer J Clin 2004;54:8-29.
3. Meirow D: Ovarian injury and modern options to preserve fertility in female cancer patients tretated with high dose radio-chemotherapy for hematooncological neoplasias and other cancers. Leuk Lymphoma 1999;33:65-76.
4. Moore HC: Following treatment for breast cancer. The incidence of treatment-related amenorrhea is related to patient age and to the treatment regimen. Curr Oncol Rep 2000;2:587-593.
5. Meirow D, Nugent D: The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod 2001;7:535-543.
6. Meirow D, Epstein M, Lewis H: Administration of cyclophosphamide at different stages of follicular maturation in mice: Effects on reproductive performance and fetal malformations. Hum Reprod 2001;16:632-637.
7. Franchi-Rezgui P, Rousselot P, Espie M, Briere J, Pierre Marolleau J, Gisselbrecht C, Brice P: Fertility in young women after chemotherapy with alkylating agents for Hodgkin and non-Hodgkin lymphomas. Hematol J 2003;4:116-120.
8. Beckmann MW: Fertility preservations of patients at risk in German reproductive university centres - a concept paper. Geburtsh Frauenheilk 2006;66:241-251.
9. Ayhan A, Celik H, Taskiran C, Bozdag G, Aksu T: Oncologic and reproductive outcome after fertilitysaving surgery in ovarian cancer. Eur J Gynaecol Oncol 2003;24:223-232.
10. Shepard JH, Milliken DA: Conservative surgery for carcinoma of the cervix. Clin Oncol 2008;20:395-400.
11. Blumenfeld Z, von Wolff M: GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod Update 2008;14:541-542.
12. Giuseppe L, Attilio G, Edoardo DN, Loredana G, Cristina L, Vincenzo L: Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). Hematology 2007;12:141-147.
13. Sverrisdottir A, Nystedt M, Johansson H, Fornander T: Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. Breast Cancer Res Treat 2009;117:561-567.
14. Stearns V, Schneider B, Henry NL, Hayes DF, Flockhart DA: Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants. Nat Rev Cancer 2006;6:886-893.
15. Tucker MG, Wright G, Morton PC, Massey JB: Birth after cryopreservation of immature ooctyes with subsequent in vitro maturation. Fertil Steril 1998;70:578-579.
16. Donnez J, Dolmans MM, Demylle D, Jadoul P, Priard C, Squifflet J, Martinez-Madrid B, van Langendonckt A: Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;364:1405-1410.
17. Kim SS, Lee WS, Chung MK, Lee HC, Lee HH, Hill D: Long-term ovarian function and fertility after heterotopic autotransplantation of cryobanked human ovarian tissue: 8-year experience in cancer patients. Fertil Steril 2009;91:2349-2354.
18. Sonmezer M, Oktay K: Fertility preservation in female patients. Hum Reprod Update 2004;10:251-266.